All Comments by

  1. Stuart Pickering-Brown on Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.
  2. Steve Barger on What If It’s Not Garden-Variety AD? Telling Variants Apart by Where Tau Is
  3. Gerhard Koenig and Jean-Francois Blain on Lessons from a failed γ-secretase Alzheimer trial.
  4. Cedric Wesley on Lessons from a failed γ-secretase Alzheimer trial.
  5. Peter Nelson on PART is part of Alzheimer disease.
  6. Rita Guerreiro on Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States.
  7. Frances Edwards on A Genome-wide Gene-Expression Analysis and Database in Transgenic Mice during Development of Amyloid or Tau Pathology.
  8. Craig Atwood on In Aging Brain, Blood-Brain Barrier Starts Leaking in Hippocampus
  9. Pieter Jelle Visser and Daniela Bertens on Large Studies Agree: Brain Amyloid Accelerates Cognitive Decline
  10. Miguel Mike Pappolla on Leaky Blood-Brain Barrier a Harbinger of Alzheimer's?
  11. Piet Eikelenboom and Jeroen Hoozemans on A Genome-wide Gene-Expression Analysis and Database in Transgenic Mice during Development of Amyloid or Tau Pathology.
  12. Chien-Ping Ko on Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model.
  13. Christina Chan on A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity.
  14. Evgenia Salta and Bart De Strooper on A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity.
  15. Virgil Muresan on Reply: the early pathological process in sporadic Alzheimer's disease.